Medical Care
Global Alzheimer's Treatment Drugs Market Research Report 2025
- Mar 11, 25
- ID: 77662
- Pages: 89
- Figures: 86
- Views: 30
The global market for Alzheimer's Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Treatment Drugs.
The Alzheimer's Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Co., Ltd.
Novartis AG
Abbvie inc. (Allergan Plc)
Adamas Pharmaceuticals, Inc.
H. Lundbeck A/S
Biogen
AC Immune
DAIICHI SANKYO COMPANY, LIMITED
Johnson & Johnson Services Inc
TauRx Pharmaceuticals Ltd
F. Hoffmann La Roche Ltd.
Segment by Type
Cholinesterase Inhibitors
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Combination Drug
Others
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Treatment Drugs.
The Alzheimer's Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Co., Ltd.
Novartis AG
Abbvie inc. (Allergan Plc)
Adamas Pharmaceuticals, Inc.
H. Lundbeck A/S
Biogen
AC Immune
DAIICHI SANKYO COMPANY, LIMITED
Johnson & Johnson Services Inc
TauRx Pharmaceuticals Ltd
F. Hoffmann La Roche Ltd.
Segment by Type
Cholinesterase Inhibitors
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Combination Drug
Others
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cholinesterase Inhibitors
1.2.3 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
1.2.4 Combination Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Treatment Drugs Market Perspective (2020-2031)
2.2 Global Alzheimer's Treatment Drugs Growth Trends by Region
2.2.1 Global Alzheimer's Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Treatment Drugs Market Dynamics
2.3.1 Alzheimer's Treatment Drugs Industry Trends
2.3.2 Alzheimer's Treatment Drugs Market Drivers
2.3.3 Alzheimer's Treatment Drugs Market Challenges
2.3.4 Alzheimer's Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Treatment Drugs Players by Revenue
3.1.1 Global Top Alzheimer's Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer's Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Treatment Drugs Revenue
3.4 Global Alzheimer's Treatment Drugs Market Concentration Ratio
3.4.1 Global Alzheimer's Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Treatment Drugs Revenue in 2024
3.5 Global Key Players of Alzheimer's Treatment Drugs Head office and Area Served
3.6 Global Key Players of Alzheimer's Treatment Drugs, Product and Application
3.7 Global Key Players of Alzheimer's Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Treatment Drugs Breakdown Data by Type
4.1 Global Alzheimer's Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Treatment Drugs Breakdown Data by Application
5.1 Global Alzheimer's Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Treatment Drugs Market Size (2020-2031)
6.2 North America Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Treatment Drugs Market Size (2020-2031)
7.2 Europe Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Treatment Drugs Market Size (2020-2031)
9.2 Latin America Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eisai Co., Ltd.
11.1.1 Eisai Co., Ltd. Company Details
11.1.2 Eisai Co., Ltd. Business Overview
11.1.3 Eisai Co., Ltd. Alzheimer's Treatment Drugs Introduction
11.1.4 Eisai Co., Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.1.5 Eisai Co., Ltd. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Alzheimer's Treatment Drugs Introduction
11.2.4 Novartis AG Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 Abbvie inc. (Allergan Plc)
11.3.1 Abbvie inc. (Allergan Plc) Company Details
11.3.2 Abbvie inc. (Allergan Plc) Business Overview
11.3.3 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Introduction
11.3.4 Abbvie inc. (Allergan Plc) Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.3.5 Abbvie inc. (Allergan Plc) Recent Development
11.4 Adamas Pharmaceuticals, Inc.
11.4.1 Adamas Pharmaceuticals, Inc. Company Details
11.4.2 Adamas Pharmaceuticals, Inc. Business Overview
11.4.3 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Introduction
11.4.4 Adamas Pharmaceuticals, Inc. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.4.5 Adamas Pharmaceuticals, Inc. Recent Development
11.5 H. Lundbeck A/S
11.5.1 H. Lundbeck A/S Company Details
11.5.2 H. Lundbeck A/S Business Overview
11.5.3 H. Lundbeck A/S Alzheimer's Treatment Drugs Introduction
11.5.4 H. Lundbeck A/S Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.5.5 H. Lundbeck A/S Recent Development
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Alzheimer's Treatment Drugs Introduction
11.6.4 Biogen Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.6.5 Biogen Recent Development
11.7 AC Immune
11.7.1 AC Immune Company Details
11.7.2 AC Immune Business Overview
11.7.3 AC Immune Alzheimer's Treatment Drugs Introduction
11.7.4 AC Immune Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.7.5 AC Immune Recent Development
11.8 DAIICHI SANKYO COMPANY, LIMITED
11.8.1 DAIICHI SANKYO COMPANY, LIMITED Company Details
11.8.2 DAIICHI SANKYO COMPANY, LIMITED Business Overview
11.8.3 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Introduction
11.8.4 DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.8.5 DAIICHI SANKYO COMPANY, LIMITED Recent Development
11.9 Johnson & Johnson Services Inc
11.9.1 Johnson & Johnson Services Inc Company Details
11.9.2 Johnson & Johnson Services Inc Business Overview
11.9.3 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Introduction
11.9.4 Johnson & Johnson Services Inc Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.9.5 Johnson & Johnson Services Inc Recent Development
11.10 TauRx Pharmaceuticals Ltd
11.10.1 TauRx Pharmaceuticals Ltd Company Details
11.10.2 TauRx Pharmaceuticals Ltd Business Overview
11.10.3 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Introduction
11.10.4 TauRx Pharmaceuticals Ltd Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.10.5 TauRx Pharmaceuticals Ltd Recent Development
11.11 F. Hoffmann La Roche Ltd.
11.11.1 F. Hoffmann La Roche Ltd. Company Details
11.11.2 F. Hoffmann La Roche Ltd. Business Overview
11.11.3 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Introduction
11.11.4 F. Hoffmann La Roche Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.11.5 F. Hoffmann La Roche Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cholinesterase Inhibitors
1.2.3 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
1.2.4 Combination Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Treatment Drugs Market Perspective (2020-2031)
2.2 Global Alzheimer's Treatment Drugs Growth Trends by Region
2.2.1 Global Alzheimer's Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Treatment Drugs Market Dynamics
2.3.1 Alzheimer's Treatment Drugs Industry Trends
2.3.2 Alzheimer's Treatment Drugs Market Drivers
2.3.3 Alzheimer's Treatment Drugs Market Challenges
2.3.4 Alzheimer's Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Treatment Drugs Players by Revenue
3.1.1 Global Top Alzheimer's Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer's Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Treatment Drugs Revenue
3.4 Global Alzheimer's Treatment Drugs Market Concentration Ratio
3.4.1 Global Alzheimer's Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Treatment Drugs Revenue in 2024
3.5 Global Key Players of Alzheimer's Treatment Drugs Head office and Area Served
3.6 Global Key Players of Alzheimer's Treatment Drugs, Product and Application
3.7 Global Key Players of Alzheimer's Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Treatment Drugs Breakdown Data by Type
4.1 Global Alzheimer's Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Treatment Drugs Breakdown Data by Application
5.1 Global Alzheimer's Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Treatment Drugs Market Size (2020-2031)
6.2 North America Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Treatment Drugs Market Size (2020-2031)
7.2 Europe Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Treatment Drugs Market Size (2020-2031)
9.2 Latin America Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eisai Co., Ltd.
11.1.1 Eisai Co., Ltd. Company Details
11.1.2 Eisai Co., Ltd. Business Overview
11.1.3 Eisai Co., Ltd. Alzheimer's Treatment Drugs Introduction
11.1.4 Eisai Co., Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.1.5 Eisai Co., Ltd. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Alzheimer's Treatment Drugs Introduction
11.2.4 Novartis AG Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 Abbvie inc. (Allergan Plc)
11.3.1 Abbvie inc. (Allergan Plc) Company Details
11.3.2 Abbvie inc. (Allergan Plc) Business Overview
11.3.3 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Introduction
11.3.4 Abbvie inc. (Allergan Plc) Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.3.5 Abbvie inc. (Allergan Plc) Recent Development
11.4 Adamas Pharmaceuticals, Inc.
11.4.1 Adamas Pharmaceuticals, Inc. Company Details
11.4.2 Adamas Pharmaceuticals, Inc. Business Overview
11.4.3 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Introduction
11.4.4 Adamas Pharmaceuticals, Inc. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.4.5 Adamas Pharmaceuticals, Inc. Recent Development
11.5 H. Lundbeck A/S
11.5.1 H. Lundbeck A/S Company Details
11.5.2 H. Lundbeck A/S Business Overview
11.5.3 H. Lundbeck A/S Alzheimer's Treatment Drugs Introduction
11.5.4 H. Lundbeck A/S Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.5.5 H. Lundbeck A/S Recent Development
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Alzheimer's Treatment Drugs Introduction
11.6.4 Biogen Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.6.5 Biogen Recent Development
11.7 AC Immune
11.7.1 AC Immune Company Details
11.7.2 AC Immune Business Overview
11.7.3 AC Immune Alzheimer's Treatment Drugs Introduction
11.7.4 AC Immune Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.7.5 AC Immune Recent Development
11.8 DAIICHI SANKYO COMPANY, LIMITED
11.8.1 DAIICHI SANKYO COMPANY, LIMITED Company Details
11.8.2 DAIICHI SANKYO COMPANY, LIMITED Business Overview
11.8.3 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Introduction
11.8.4 DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.8.5 DAIICHI SANKYO COMPANY, LIMITED Recent Development
11.9 Johnson & Johnson Services Inc
11.9.1 Johnson & Johnson Services Inc Company Details
11.9.2 Johnson & Johnson Services Inc Business Overview
11.9.3 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Introduction
11.9.4 Johnson & Johnson Services Inc Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.9.5 Johnson & Johnson Services Inc Recent Development
11.10 TauRx Pharmaceuticals Ltd
11.10.1 TauRx Pharmaceuticals Ltd Company Details
11.10.2 TauRx Pharmaceuticals Ltd Business Overview
11.10.3 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Introduction
11.10.4 TauRx Pharmaceuticals Ltd Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.10.5 TauRx Pharmaceuticals Ltd Recent Development
11.11 F. Hoffmann La Roche Ltd.
11.11.1 F. Hoffmann La Roche Ltd. Company Details
11.11.2 F. Hoffmann La Roche Ltd. Business Overview
11.11.3 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Introduction
11.11.4 F. Hoffmann La Roche Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025)
11.11.5 F. Hoffmann La Roche Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alzheimer's Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Table 4. Key Players of Combination Drug
Table 5. Key Players of Others
Table 6. Global Alzheimer's Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer's Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer's Treatment Drugs Market Share by Region (2020-2025)
Table 10. Global Alzheimer's Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer's Treatment Drugs Market Share by Region (2026-2031)
Table 12. Alzheimer's Treatment Drugs Market Trends
Table 13. Alzheimer's Treatment Drugs Market Drivers
Table 14. Alzheimer's Treatment Drugs Market Challenges
Table 15. Alzheimer's Treatment Drugs Market Restraints
Table 16. Global Alzheimer's Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer's Treatment Drugs Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer's Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2024)
Table 19. Ranking of Global Top Alzheimer's Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer's Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer's Treatment Drugs, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer's Treatment Drugs, Product and Application
Table 23. Global Key Players of Alzheimer's Treatment Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer's Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer's Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eisai Co., Ltd. Company Details
Table 49. Eisai Co., Ltd. Business Overview
Table 50. Eisai Co., Ltd. Alzheimer's Treatment Drugs Product
Table 51. Eisai Co., Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 52. Eisai Co., Ltd. Recent Development
Table 53. Novartis AG Company Details
Table 54. Novartis AG Business Overview
Table 55. Novartis AG Alzheimer's Treatment Drugs Product
Table 56. Novartis AG Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 57. Novartis AG Recent Development
Table 58. Abbvie inc. (Allergan Plc) Company Details
Table 59. Abbvie inc. (Allergan Plc) Business Overview
Table 60. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Product
Table 61. Abbvie inc. (Allergan Plc) Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 62. Abbvie inc. (Allergan Plc) Recent Development
Table 63. Adamas Pharmaceuticals, Inc. Company Details
Table 64. Adamas Pharmaceuticals, Inc. Business Overview
Table 65. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Product
Table 66. Adamas Pharmaceuticals, Inc. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 67. Adamas Pharmaceuticals, Inc. Recent Development
Table 68. H. Lundbeck A/S Company Details
Table 69. H. Lundbeck A/S Business Overview
Table 70. H. Lundbeck A/S Alzheimer's Treatment Drugs Product
Table 71. H. Lundbeck A/S Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 72. H. Lundbeck A/S Recent Development
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Alzheimer's Treatment Drugs Product
Table 76. Biogen Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 77. Biogen Recent Development
Table 78. AC Immune Company Details
Table 79. AC Immune Business Overview
Table 80. AC Immune Alzheimer's Treatment Drugs Product
Table 81. AC Immune Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 82. AC Immune Recent Development
Table 83. DAIICHI SANKYO COMPANY, LIMITED Company Details
Table 84. DAIICHI SANKYO COMPANY, LIMITED Business Overview
Table 85. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Product
Table 86. DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 87. DAIICHI SANKYO COMPANY, LIMITED Recent Development
Table 88. Johnson & Johnson Services Inc Company Details
Table 89. Johnson & Johnson Services Inc Business Overview
Table 90. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Product
Table 91. Johnson & Johnson Services Inc Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 92. Johnson & Johnson Services Inc Recent Development
Table 93. TauRx Pharmaceuticals Ltd Company Details
Table 94. TauRx Pharmaceuticals Ltd Business Overview
Table 95. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Product
Table 96. TauRx Pharmaceuticals Ltd Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 97. TauRx Pharmaceuticals Ltd Recent Development
Table 98. F. Hoffmann La Roche Ltd. Company Details
Table 99. F. Hoffmann La Roche Ltd. Business Overview
Table 100. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Product
Table 101. F. Hoffmann La Roche Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 102. F. Hoffmann La Roche Ltd. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Treatment Drugs Picture
Figure 2. Global Alzheimer's Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Cholinesterase Inhibitors Features
Figure 5. N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Features
Figure 6. Combination Drug Features
Figure 7. Others Features
Figure 8. Global Alzheimer's Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer's Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 10. Online Sales Case Studies
Figure 11. Offline Sales Case Studies
Figure 12. Alzheimer's Treatment Drugs Report Years Considered
Figure 13. Global Alzheimer's Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Alzheimer's Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Alzheimer's Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Alzheimer's Treatment Drugs Market Share by Players in 2024
Figure 17. Global Top Alzheimer's Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Treatment Drugs Revenue in 2024
Figure 19. North America Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 21. United States Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 25. Germany Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer's Treatment Drugs Market Share by Region (2020-2031)
Figure 33. China Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Eisai Co., Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 50. Abbvie inc. (Allergan Plc) Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 51. Adamas Pharmaceuticals, Inc. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 52. H. Lundbeck A/S Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 53. Biogen Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 54. AC Immune Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 55. DAIICHI SANKYO COMPANY, LIMITED Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 56. Johnson & Johnson Services Inc Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 57. TauRx Pharmaceuticals Ltd Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 58. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Alzheimer's Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Table 4. Key Players of Combination Drug
Table 5. Key Players of Others
Table 6. Global Alzheimer's Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer's Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer's Treatment Drugs Market Share by Region (2020-2025)
Table 10. Global Alzheimer's Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer's Treatment Drugs Market Share by Region (2026-2031)
Table 12. Alzheimer's Treatment Drugs Market Trends
Table 13. Alzheimer's Treatment Drugs Market Drivers
Table 14. Alzheimer's Treatment Drugs Market Challenges
Table 15. Alzheimer's Treatment Drugs Market Restraints
Table 16. Global Alzheimer's Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer's Treatment Drugs Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer's Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2024)
Table 19. Ranking of Global Top Alzheimer's Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer's Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer's Treatment Drugs, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer's Treatment Drugs, Product and Application
Table 23. Global Key Players of Alzheimer's Treatment Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer's Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer's Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eisai Co., Ltd. Company Details
Table 49. Eisai Co., Ltd. Business Overview
Table 50. Eisai Co., Ltd. Alzheimer's Treatment Drugs Product
Table 51. Eisai Co., Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 52. Eisai Co., Ltd. Recent Development
Table 53. Novartis AG Company Details
Table 54. Novartis AG Business Overview
Table 55. Novartis AG Alzheimer's Treatment Drugs Product
Table 56. Novartis AG Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 57. Novartis AG Recent Development
Table 58. Abbvie inc. (Allergan Plc) Company Details
Table 59. Abbvie inc. (Allergan Plc) Business Overview
Table 60. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Product
Table 61. Abbvie inc. (Allergan Plc) Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 62. Abbvie inc. (Allergan Plc) Recent Development
Table 63. Adamas Pharmaceuticals, Inc. Company Details
Table 64. Adamas Pharmaceuticals, Inc. Business Overview
Table 65. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Product
Table 66. Adamas Pharmaceuticals, Inc. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 67. Adamas Pharmaceuticals, Inc. Recent Development
Table 68. H. Lundbeck A/S Company Details
Table 69. H. Lundbeck A/S Business Overview
Table 70. H. Lundbeck A/S Alzheimer's Treatment Drugs Product
Table 71. H. Lundbeck A/S Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 72. H. Lundbeck A/S Recent Development
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Alzheimer's Treatment Drugs Product
Table 76. Biogen Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 77. Biogen Recent Development
Table 78. AC Immune Company Details
Table 79. AC Immune Business Overview
Table 80. AC Immune Alzheimer's Treatment Drugs Product
Table 81. AC Immune Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 82. AC Immune Recent Development
Table 83. DAIICHI SANKYO COMPANY, LIMITED Company Details
Table 84. DAIICHI SANKYO COMPANY, LIMITED Business Overview
Table 85. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Product
Table 86. DAIICHI SANKYO COMPANY, LIMITED Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 87. DAIICHI SANKYO COMPANY, LIMITED Recent Development
Table 88. Johnson & Johnson Services Inc Company Details
Table 89. Johnson & Johnson Services Inc Business Overview
Table 90. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Product
Table 91. Johnson & Johnson Services Inc Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 92. Johnson & Johnson Services Inc Recent Development
Table 93. TauRx Pharmaceuticals Ltd Company Details
Table 94. TauRx Pharmaceuticals Ltd Business Overview
Table 95. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Product
Table 96. TauRx Pharmaceuticals Ltd Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 97. TauRx Pharmaceuticals Ltd Recent Development
Table 98. F. Hoffmann La Roche Ltd. Company Details
Table 99. F. Hoffmann La Roche Ltd. Business Overview
Table 100. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Product
Table 101. F. Hoffmann La Roche Ltd. Revenue in Alzheimer's Treatment Drugs Business (2020-2025) & (US$ Million)
Table 102. F. Hoffmann La Roche Ltd. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Treatment Drugs Picture
Figure 2. Global Alzheimer's Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Cholinesterase Inhibitors Features
Figure 5. N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Features
Figure 6. Combination Drug Features
Figure 7. Others Features
Figure 8. Global Alzheimer's Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer's Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 10. Online Sales Case Studies
Figure 11. Offline Sales Case Studies
Figure 12. Alzheimer's Treatment Drugs Report Years Considered
Figure 13. Global Alzheimer's Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Alzheimer's Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Alzheimer's Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Alzheimer's Treatment Drugs Market Share by Players in 2024
Figure 17. Global Top Alzheimer's Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Treatment Drugs Revenue in 2024
Figure 19. North America Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 21. United States Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 25. Germany Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer's Treatment Drugs Market Share by Region (2020-2031)
Figure 33. China Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer's Treatment Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Alzheimer's Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Eisai Co., Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 50. Abbvie inc. (Allergan Plc) Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 51. Adamas Pharmaceuticals, Inc. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 52. H. Lundbeck A/S Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 53. Biogen Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 54. AC Immune Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 55. DAIICHI SANKYO COMPANY, LIMITED Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 56. Johnson & Johnson Services Inc Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 57. TauRx Pharmaceuticals Ltd Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 58. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Alzheimer's Treatment Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232